Telemedicine, Teleophthalmology Programs in Action at Johns Hopkins
Telemedicine, Teleophthalmology Programs in Action at Johns Hopkins
Telemedicine, Teleophthalmology Programs in Action at Johns Hopkins
Steve Lenier
April 17, 2019
Volume:
44
Issue:
7
Abstract / Synopsis:
Equipment
Both the patient and the clinician need certain tools to perform
telemedicine. For the patient these can include a laptop, smartphone, or
other personal smart device, equipped with a camera, and the
appropriate app or software. In some cases remote monitoring
equipment at home can be useful as well. The physician will need similar
equipment, plus additional software and peripherals for use in
diagnosing disease or progression and reporting results.
Modes
There are three main types of telemedicine, each good for certain uses.
Only one of them (synchronous) requires the physician and patient to be
available at the same time. Telehealth makes individualized, patient-
centric care possible for patients across the continuum of care.
Locations Served
At Johns Hopkins, telemedicine connects the entire healthcare system
including community physician practices, all Johns Hopkins’ hospitals,
affiliated hospitals, the home-care group, skilled-nursing facilities, and
other collaborative facilities.
Challenges
Many challenges remain in using telemedicine, most significant of which
include policies and reimbursement.
While the telehealth market continues to grow, telemedicine volumes
expand at the speed of reimbursement. Commercial payors have largely
embraced telemedicine but government payors (Medicare and Medicaid)
have been more reluctant. There has been an uptick in reimbursement
for telemedicine services from government payors.
Without appropriate reimbursement, providers will not utilize new
technology tools for health care delivery. Direct-to-consumer online
virtual care has been more successful with self-pay options. Other
notable concerns include obtaining licensing to practice medicine across
state lines (a medical license is required in the state where the patient is
located), and credentialing and privileging at the originating site.
Diving deeper: Teleophthalmology
Ingrid Zimmer-Galler, MD, associate professor of ophthalmology at
the Johns Hopkins Wilmer Eye Institute, points out that
teleophthalmology has the potential to be a radical transformer of care
delivery.
The FDA recently cleared the first artificial intelligence system for use in
the United States for diabetic retinopathy screening. This is expected to
enhance the efficiency of diabetic retinopathy screening as physician
review of every image will no longer be necessary.
Disclosures:
Ingrid Zimmer-Galler, MD
E: [email protected]
This article was adapted from Dr. Zimmer-Galler’s presentation at the
2018 meeting of the Johns Hopkins’ Wilmer Eye Institute Current
Concepts in Ophthalmology in Baltimore. Dr. Zimmer-Galler has no
financial interests to disclose.